Étude de phase 2, randomisée, évaluant une polychimiothérapie orale (CCNU, Cyclophosphamide, étoposide) et une polychimiothérapie intraveineuse dans les cancers bronchiques à petites cellules en seconde ligne en rechute (essai GFPC0501) (Q60473154)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 May 2007

Language	Label	Description	Also known as
English	Étude de phase 2, randomisée, évaluant une polychimiothérapie orale (CCNU, Cyclophosphamide, étoposide) et une polychimiothérapie intraveineuse dans les cancers bronchiques à petites cellules en seconde ligne en rechute (essai GFPC0501)	scientific article published on 01 May 2007

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17519820%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

[Randomised phase II study evaluating oral combination chemotherapy (CCNU, cyclophosphamide, etoposide) and intravenous chemotherapy as second-line treatment for relapsed small cell bronchial carcinoma (Trial GFPC0501)] (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17519820%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Christos Chouaid

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17519820%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

author name string

R Gervais

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17519820%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Y Le Guen

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17519820%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

H Le Caer

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17519820%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

D Paillotin

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17519820%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

GFPC

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17519820%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

publication date

1 May 2007

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17519820%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Revue des Maladies Respiratoires

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17519820%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

24

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17519820%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17519820%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

653-658

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17519820%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Retreatment with the induction regimen in small cell lung cancer relapsing after an initial response to short term chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8425%2807%2991136-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of relapsed small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8425%2807%2991136-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II study of daily oral etoposide plus ifosfamide plus cisplatin for previously treated recurrent small-cell lung cancer: a Hoosier Oncology Group Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8425%2807%2991136-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Second-line chemotherapy and its evaluation in small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8425%2807%2991136-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II study of paclitaxel, ifosfamide, and cisplatin as second-line treatment in relapsed small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8425%2807%2991136-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemotherapy in small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8425%2807%2991136-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Teniposide and etoposide in previously untreated small-cell lung cancer: a randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8425%2807%2991136-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Etoposide in the treatment of elderly/poor-prognosis patients with small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8425%2807%2991136-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Current role of oral etoposide in the management of small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8425%2807%2991136-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of oral etoposide in non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8425%2807%2991136-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Feasibility of oral topotecan in previously untreated patients with small-cell lung cancer ineligible for standard therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8425%2807%2991136-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of oral etoposide and standard intravenous multidrug chemotherapy for small-cell lung cancer: a stopped multicentre randomised trial. Medical Research Council Lung Cancer Working Party.

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8425%2807%2991136-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Cisplatin, ifosfamide, oral etoposide, and concurrent accelerated hyperfractionated thoracic radiation for patients with limited small-cell lung carcinoma: results of radiation therapy oncology group trial 93-12.

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8425%2807%2991136-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Outpatient treatment with epirubicin and oral etoposide in patients with small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8425%2807%2991136-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination chemotherapy with low doses of weekly Carboplatin and oral Etoposide in poor risk small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8425%2807%2991136-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II trial of oral etoposide plus cisplatin in extensive stage small cell carcinoma of the lung: an Eastern Cooperative Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8425%2807%2991136-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase II study of oral etoposide in elderly patients with small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8425%2807%2991136-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Schedule dependency of 21-day oral versus 3-day intravenous etoposide in combination with intravenous cisplatin in extensive-stage small-cell lung cancer: a randomized phase III study of the Cancer and Leukemia Group B

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8425%2807%2991136-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II trial of carboplatin plus oral etoposide for elderly patients with small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8425%2807%2991136-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A Phase I-II study of sequential administration of topotecan and oral etoposide (toposiomerase I and II inhibitors) in the treatment of patients with small cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8425%2807%2991136-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of poor-prognosis extensive disease small-cell lung cancer with an all-oral regimen of etoposide and cyclophosphamide - a Southwest Oncology Group clinical and pharmacokinetic study

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8425%2807%2991136-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Quality-of-life assessment in cancer treatment protocols: research issues in protocol development

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8425%2807%2991136-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0761-8425(07)91136-5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17519820%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17519820%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q60473154&oldid=1949132131"